Treatment of Radiation Mucositis
The treatment of radiation mucositis should include frequent non-medicated saline oral rinses (4-6 times/day), pain management with topical anesthetics, and benzydamine oral rinse for prevention in patients receiving moderate-dose radiation therapy. 1
Basic Oral Care
- Implement multidisciplinary oral care protocols that include frequent use of non-medicated saline mouth rinses (4-6 times/day) to reduce severity of oral mucositis 1
- Use a soft toothbrush that is replaced regularly as part of systematic oral care protocols 1
- Avoid alcohol-based mouth rinses as they can irritate damaged mucosa 1
- Regular oral pain assessment using validated instruments for self-reporting is essential for proper management 1
Pain Management
- Patient-controlled analgesia with morphine is recommended as the treatment of choice for severe oral mucositis pain, particularly in patients undergoing hematopoietic stem cell transplantation (HSCT) 1
- Topical anesthetics can provide short-term pain relief for oral mucositis on an empiric basis 1
- Follow the modified WHO analgesia ladder for symptomatic treatment 1
Preventive Measures for Radiation-Induced Mucositis
- Use midline radiation blocks and three-dimensional radiation treatment techniques to reduce mucosal injury 1
- Benzydamine oral rinse is recommended for prevention of radiation-induced mucositis in patients with head and neck cancer receiving moderate-dose radiation therapy 1
- Low-level laser therapy (LLLT) is suggested to reduce incidence of oral mucositis and associated pain in patients receiving high-dose chemotherapy or chemoradiotherapy 1, 2
Treatments NOT Recommended
- Chlorhexidine is not recommended for prevention or treatment of oral mucositis in patients with solid tumors of the head and neck who are undergoing radiotherapy 1
- Antimicrobial lozenges are not recommended for prevention of radiation-induced oral mucositis 1
- Sucralfate is not recommended for prevention of radiation-induced oral mucositis 1
Nutritional Support
- Screen all patients for nutritional risk due to high risk of malnutrition following chemoradiotherapy 1
- Initiate early enteral nutrition in case of swallowing problems 1
- Consider referral to a nutrition team for patients at risk of malnutrition 1
Special Considerations for Chemotherapy-Induced Mucositis
- Oral cryotherapy (30 minutes) is recommended for prevention of oral mucositis in patients receiving bolus 5-FU chemotherapy 1
- Palifermin (keratinocyte growth factor-1) is recommended at a dose of 60 μg/kg/day for 3 days before conditioning treatment and for 3 days post-transplant for prevention of oral mucositis in patients with hematological malignancies receiving high-dose chemotherapy and total body irradiation with autologous stem cell transplant 1, 3
- Cryotherapy is suggested to prevent oral mucositis in patients receiving high-dose melphalan 1
Management of Severe Cases
- Exclude HSV, CMV, and extensive candidiasis in patients with persistent painful mucositis 1
- For patients with radiation-induced proctitis who have rectal bleeding, sucralfate enemas are suggested 1
- Consider the use of growth factors like palifermin in specific clinical scenarios, particularly for patients undergoing HSCT 3
Common Pitfalls and Caveats
- Do not administer palifermin within 24 hours of chemotherapy, as this can increase sensitivity of rapidly dividing epithelial cells and potentially worsen mucositis 3
- Avoid chlorhexidine for treatment of established oral mucositis as it has been shown to be ineffective 1
- Be aware that palifermin may not be effective in all treatment regimens - it showed lack of efficacy in patients receiving high-dose melphalan and in allogeneic transplantation 3
- Monitor for potential cataract development in patients receiving palifermin treatment 3